Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Gemigliptin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    MARKET PLACE

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 LG Chem
    South Korea
    		 LG Chemical Co., Ltd. 2427-2-ND Gemigliptin tartrate 2012-06-01 LG Chemical Co., Ltd. South Korea 19 Ijin-ro, Onsan-eup, Ulju-gun, Ulsan
    28/09/2024 LG Chem
    South Korea
    		 LG Chemical Co., Ltd. 1543-5-ND Gemigliptin tartrate 2014-12-15 LG Chemical Co., Ltd. South Korea 129 Seokam-ro, Iksan-si, Jeollabuk-do